Company Directory / biotechnology
PrivateFor profitbiotechnologyCambridge, United States
GentiBio
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
- Founded
- 2020 6 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $177M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
6 years old.
Reach
Website ranked #4,001,946 in the world for traffic, about 3k visits a month.
What it does
BiotechnologyLife Science
Funding, as listed
$177M currency not stated
- Rounds2
- LatestSeries a, Aug 2021
- Investors7, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about GentiBio, field by field. Contact details are held but never shown.
The company
- Name
- GentiBio
- Type
- For profit
- Status
- Private
- Founded
- 2020
- Founders
- Adel Nada, Andy Walker
- Industry
- biotechnology
- Categories
- Biotechnology, Life Science
Where
- City
- Cambridge
- Country
- United States
- Markets
- Greater Seattle Area, West Coast, Western US
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #4,001,946
- Monthly web visits
- 2,711
Funding, as listed
- Total
- 177,000,000 (currency not stated)
- Rounds
- 2
- Latest round
- Series a
- Latest round date
- Aug 2021
- Investors
- 7
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.